Vectura Inks Asthma/COPD License Agreement with Janssen – Genetic Engineering & Biotechnology News

Vectura Inks Asthma/COPD License Agreement with Janssen
Genetic Engineering & Biotechnology News
Vectura, a respiratory product development company, has entered a license agreement with Janssen Biotech to exclusively develop anti-inflammatory therapies for the treatment of asthma/COPD. The collaboration will initially focus on the development of a …

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.